JITC

Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression
Katherine P Mueller, Nicole J Piscopo, Matthew H Forsberg, Louise A Saraspe, Amritava Das, Brittany Russell, Madeline Smerchansky, Dan Cappabianca, Lei Shi, Keerthana Shankar, Lauren Sarko, Namita Khajanchi, Nina La Vonne Denne, Apoorva Ramamurthy, Adeela Ali, Cicera R Lazzarotto, Shengdar Q Tsai, Christian M Capitini, Krishanu Saha

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004446; DOI: 10.1136/jitc-2021-004446
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer
Thomas A Odeny, Kathryn Lurain, Julius Strauss, Steven P Fling, Elad Sharon, Anna Wright, Javier Martinez-Picado, Teresa Moran, James L Gulley, Maria Gonzalez-Cao, Thomas S Uldrick, Robert Yarchoan, Ramya Ramaswami

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005128; DOI: 10.1136/jitc-2022-005128
Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?
Winnie G Vos, Esther Lutgens, Tom T P Seijkens

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005611; DOI: 10.1136/jitc-2022-005611
Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy
Dayana Blokon-Kogan, Maya Levi-Mann, Lior Malka-Levy, Orit Itzhaki, Michal J Besser, Yuval Shiftan, Árpád Szöőr, György Vereb, Gideon Gross, Hinrich Abken, Hadas Weinstein-Marom

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e001544; DOI: 10.1136/jitc-2020-001544
Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
Nithya Krishnamurthy, Shumei Kato, Scott Lippman, Razelle Kurzrock

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004669; DOI: 10.1136/jitc-2022-004669
IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts
Lujun Chen, Hao Huang, Xiao Zheng, Yuan Li, Junjun Chen, Bo Tan, Yingting Liu, Runzi Sun, Bin Xu, Min Yang, Bin Li, Changping Wu, Binfeng Lu, Jingting Jiang

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004585; DOI: 10.1136/jitc-2022-004585
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL
Tingting Zhang, Hengqi Liu, Lei Jiao, Zhenzhen Zhang, Jin He, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong, Bin Meng, Xiubao Ren, Huilai Zhang, Xianhuo Wang

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004114; DOI: 10.1136/jitc-2021-004114
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, I Jolanda M de Vries, Carl G Figdor, Georgina Flórez-Grau, Martijn Verdoes

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004309; DOI: 10.1136/jitc-2021-004309
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
Yongxiang Xia, Weiwei Tang, Xiaofeng Qian, Xiangcheng Li, Feng Cheng, Ke Wang, Feng Zhang, Chuanyong Zhang, Donghua Li, Jinhua Song, Hui Zhang, Jie Zhao, Aihua Yao, Xiaofeng Wu, Chen Wu, Guwei Ji, Xisheng Liu, Feipeng Zhu, Lang Qin, Xuan Xiao, Zhenhua Deng, Xiangyi Kong, Si Li, Yangyang Yu, Wenjing Xi, Wanglong Deng, Chuang Qi, Hanyuan Liu, Liyong Pu, Ping Wang, Xuehao Wang

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004656; DOI: 10.1136/jitc-2022-004656
Tumor-associated macrophages in multiple myeloma: advances in biology and therapy
Jennifer Sun, Chaelee Park, Nicole Guenthner, Shannon Gurley, Luna Zhang, Berit Lubben, Ola Adebayo, Hannah Bash, Yixuan Chen, Mina Maksimos, Barbara Muz, Abdel Kareem Azab

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e003975; DOI: 10.1136/jitc-2021-003975

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages